Antimicrobial Peptide LL‑37 Contributes to Thrombotic Complications in Patients With COVID‑19
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
Cytomegalovirus and Varicella Zoster Virus-Related Uveitic Secondary Glaucoma.
Researchers sought to determine the underlying reasons for thrombosis risk in patients with severe COVID-19.